News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AHF: CA State Treasurer Lockyer Urges Gilead Sciences, Inc. (GILD) to Show Restraint Pricing New AIDS Drug the "Quad"


6/28/2012 10:05:52 AM

SACRAMENTO, Calif.--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) announced that California State Treasurer Bill Lockyer has sent a letter to California-based drug company, Gilead Sciences, Inc. urging the company to set an initial price on its latest HIV/AIDS drug combination—which is known as the ‘Quad’—that is “…sensitive to ongoing state budget difficulties,” and which will also“…provide the means to keep people with HIV/AIDS alive and as healthy as possible.”

Read at BioSpace.com


comments powered by Disqus
   
HIV/AIDS

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES